Across four distinct strains it was observed that the flower samples taken from the upper third of the plant had a higher THC content than those at the base of the plant, and in two of the strains tested the difference was equivalent to the upper flowers being around twice as potent as the lower flowers.
Whether it is introduced at the cultivator, processor or manufacturer level, ETCH biotrace links a unique molecular tag to the cannabis plant that will survive conversion or extraction.
The researchers behind the work were keen to point out that there is still little evidence to prove that the pathogens present in cannabis samples have directly led to infections in immunocompromised patients.
Examining a broad array of cannabinoids and terpenes reveals the inherent failings of commonly used cannabis classification systems.
The patent, Production of Cannabidiolic Acid in Yeast, describes the modification of yeast to produce CBDA from simple feedstocks such as sugar.
Whilst the safety profile of cannabis is well understood, much more research is required to understand and address the challenge of cannabis contamination.
Based on smell alone, consumers appear unable to determine the potency of cannabis but can accurately group strains together.
As the industry develops there comes a need to consistently produce and test for certain characteristics, like cannabinoid and terpene profiles, in order to achieve the desired results.
Inconsistent naming and labeling of cannabis strains continue to pose challenges for consumers and researchers alike.
Canopy Growth and MSC will work together to pioneer new and standardized testing methods to analyse potency, terpene profiling, pesticides, heavy metals, and mycotoxins as required by Health Canada regulatory standards.